Product
Continue previous treatment
1 clinical trial
1 indication
Clinical trial
A Multicenter, Prospective, Cohort Study on the Treatment of Metastatic Hormone-sensitive Prostate Cancer Patients Who Have Progressed After Pre-treatment With Rezvilutamide Combined With AbirateroneStatus: Not yet recruiting, Estimated PCD: 2025-04-30